LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29 (suppl_8) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | suppl_8 |
| container_start_page | |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Cascone, T William, W N Weissferdt, A Leung, C H Federico, L Haymaker, C Bernatchez, C Fossella, F V Mott, F E Papadimitrakopoulou, V A Byers, L Lam, V K Godoy, M C Carter, B Lee, J J Vaporciyan, A Gibbons, D L Swisher, S G Heymach, J V Sepesi, B |
| description | |
| doi_str_mv | 10.1093/annonc/mdy424.059 |
| format | Article |
| fullrecord | <record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdy424_059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy424.059</oup_id><sourcerecordid>10.1093/annonc/mdy424.059</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdy424_0593</originalsourceid><addsrcrecordid>eNqVj81KAzEYRYMoOP48gLssHXDaLzOZapY6KAqlm3YfvqappORnSJpC395Iu3Dr5l64nMU9hDwwmDAQ3RS9D15N3ebIWz6BXlyQivUz0bwAZ5ekAtF2zXPf8Wtyk9IOAGaiFRWJ87dXLhY64GaXD-j31JtDsNnhmj4uahrin2G0OVEzGmvcGfiq6bYgUSet9ri2mpYbTXJoLVW6hM3-myr0SseCL4f5UN-Rqy3apO_PfUuePt5Xw2cT8ijHaBzGo2Qgf73kyUuevGTx6v6J_wCB51eY</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Cascone, T ; William, W N ; Weissferdt, A ; Leung, C H ; Federico, L ; Haymaker, C ; Bernatchez, C ; Fossella, F V ; Mott, F E ; Papadimitrakopoulou, V A ; Byers, L ; Lam, V K ; Godoy, M C ; Carter, B ; Lee, J J ; Vaporciyan, A ; Gibbons, D L ; Swisher, S G ; Heymach, J V ; Sepesi, B</creator><creatorcontrib>Cascone, T ; William, W N ; Weissferdt, A ; Leung, C H ; Federico, L ; Haymaker, C ; Bernatchez, C ; Fossella, F V ; Mott, F E ; Papadimitrakopoulou, V A ; Byers, L ; Lam, V K ; Godoy, M C ; Carter, B ; Lee, J J ; Vaporciyan, A ; Gibbons, D L ; Swisher, S G ; Heymach, J V ; Sepesi, B</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy424.059</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 (suppl_8)</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Cascone, T</creatorcontrib><creatorcontrib>William, W N</creatorcontrib><creatorcontrib>Weissferdt, A</creatorcontrib><creatorcontrib>Leung, C H</creatorcontrib><creatorcontrib>Federico, L</creatorcontrib><creatorcontrib>Haymaker, C</creatorcontrib><creatorcontrib>Bernatchez, C</creatorcontrib><creatorcontrib>Fossella, F V</creatorcontrib><creatorcontrib>Mott, F E</creatorcontrib><creatorcontrib>Papadimitrakopoulou, V A</creatorcontrib><creatorcontrib>Byers, L</creatorcontrib><creatorcontrib>Lam, V K</creatorcontrib><creatorcontrib>Godoy, M C</creatorcontrib><creatorcontrib>Carter, B</creatorcontrib><creatorcontrib>Lee, J J</creatorcontrib><creatorcontrib>Vaporciyan, A</creatorcontrib><creatorcontrib>Gibbons, D L</creatorcontrib><creatorcontrib>Swisher, S G</creatorcontrib><creatorcontrib>Heymach, J V</creatorcontrib><creatorcontrib>Sepesi, B</creatorcontrib><title>LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVj81KAzEYRYMoOP48gLssHXDaLzOZapY6KAqlm3YfvqappORnSJpC395Iu3Dr5l64nMU9hDwwmDAQ3RS9D15N3ebIWz6BXlyQivUz0bwAZ5ekAtF2zXPf8Wtyk9IOAGaiFRWJ87dXLhY64GaXD-j31JtDsNnhmj4uahrin2G0OVEzGmvcGfiq6bYgUSet9ri2mpYbTXJoLVW6hM3-myr0SseCL4f5UN-Rqy3apO_PfUuePt5Xw2cT8ijHaBzGo2Qgf73kyUuevGTx6v6J_wCB51eY</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Cascone, T</creator><creator>William, W N</creator><creator>Weissferdt, A</creator><creator>Leung, C H</creator><creator>Federico, L</creator><creator>Haymaker, C</creator><creator>Bernatchez, C</creator><creator>Fossella, F V</creator><creator>Mott, F E</creator><creator>Papadimitrakopoulou, V A</creator><creator>Byers, L</creator><creator>Lam, V K</creator><creator>Godoy, M C</creator><creator>Carter, B</creator><creator>Lee, J J</creator><creator>Vaporciyan, A</creator><creator>Gibbons, D L</creator><creator>Swisher, S G</creator><creator>Heymach, J V</creator><creator>Sepesi, B</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20181001</creationdate><title>LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)</title><author>Cascone, T ; William, W N ; Weissferdt, A ; Leung, C H ; Federico, L ; Haymaker, C ; Bernatchez, C ; Fossella, F V ; Mott, F E ; Papadimitrakopoulou, V A ; Byers, L ; Lam, V K ; Godoy, M C ; Carter, B ; Lee, J J ; Vaporciyan, A ; Gibbons, D L ; Swisher, S G ; Heymach, J V ; Sepesi, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdy424_0593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cascone, T</creatorcontrib><creatorcontrib>William, W N</creatorcontrib><creatorcontrib>Weissferdt, A</creatorcontrib><creatorcontrib>Leung, C H</creatorcontrib><creatorcontrib>Federico, L</creatorcontrib><creatorcontrib>Haymaker, C</creatorcontrib><creatorcontrib>Bernatchez, C</creatorcontrib><creatorcontrib>Fossella, F V</creatorcontrib><creatorcontrib>Mott, F E</creatorcontrib><creatorcontrib>Papadimitrakopoulou, V A</creatorcontrib><creatorcontrib>Byers, L</creatorcontrib><creatorcontrib>Lam, V K</creatorcontrib><creatorcontrib>Godoy, M C</creatorcontrib><creatorcontrib>Carter, B</creatorcontrib><creatorcontrib>Lee, J J</creatorcontrib><creatorcontrib>Vaporciyan, A</creatorcontrib><creatorcontrib>Gibbons, D L</creatorcontrib><creatorcontrib>Swisher, S G</creatorcontrib><creatorcontrib>Heymach, J V</creatorcontrib><creatorcontrib>Sepesi, B</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cascone, T</au><au>William, W N</au><au>Weissferdt, A</au><au>Leung, C H</au><au>Federico, L</au><au>Haymaker, C</au><au>Bernatchez, C</au><au>Fossella, F V</au><au>Mott, F E</au><au>Papadimitrakopoulou, V A</au><au>Byers, L</au><au>Lam, V K</au><au>Godoy, M C</au><au>Carter, B</au><au>Lee, J J</au><au>Vaporciyan, A</au><au>Gibbons, D L</au><au>Swisher, S G</au><au>Heymach, J V</au><au>Sepesi, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)</atitle><jtitle>Annals of oncology</jtitle><date>2018-10-01</date><risdate>2018</risdate><volume>29</volume><issue>suppl_8</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdy424.059</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29 (suppl_8) |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_oup_primary_10_1093_annonc_mdy424_059 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A20%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LBA49Neoadjuvant%20nivolumab%20(N)%20or%20nivolumab%20plus%20ipilimumab%20(NI)%20for%20resectable%20non-small%20cell%20lung%20cancer%20(NSCLC)&rft.jtitle=Annals%20of%20oncology&rft.au=Cascone,%20T&rft.date=2018-10-01&rft.volume=29&rft.issue=suppl_8&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy424.059&rft_dat=%3Coup%3E10.1093/annonc/mdy424.059%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdy424.059&rfr_iscdi=true |